|
Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients |
Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients. Transfusion 2013; 54(1): 86-97 Indexing Status Subject indexing assigned by NLM MeSH Anemia, Hemolytic /economics /etiology /immunology /prevention & Anemia, Sickle Cell /economics /immunology /therapy; Blood Group Incompatibility /economics /prevention & Blood Grouping and Crossmatching /economics /methods; Cost-Benefit Analysis; Decision Trees; Erythrocyte Transfusion /adverse effects /economics /methods; Erythrocytes /immunology; Health Care Costs; Humans; Markov Chains; control; control AccessionNumber 22013021505 Date bibliographic record published 06/06/2013 |
|
|
|